Key result
TLR4 and its endogenous ligands, including galectin-3 and fibrinogen, were immunolocalized in the endothelial cells of small blood vessels in angiolipoma tissues, suggesting they contribute to vasculature formation.
Why the study?
Endothelial TLR4 activation by specific endogenous ligands and their role in small blood vessel formation in angiolipoma had not been studied.
Observational (n=7)
No
Endothelial TLR4 activation by endogenous ligands and galectin-3 lattice formation may contribute to the formation of small blood vessels in angiolipomas.
Answers are grounded in this paper and cite their sources.
TLR4 signaling may promote angiolipoma angiogenesis; hypothesis-generating and leaves open any therapeutic role.
Angiolipomas are benign subcutaneous nodules characterized by the presence of mature adipocytes intermingled with cluster of small blood vessels, often displaying intraluminal fibrin microthrombi. It is known that fibrinogen and/or fibrin intraluminal and extracellular deposition during immune responses affect Endothelial Cell (EC) functioning and leukocyte trafficking. Also, it is known that Toll-Like Receptors (TLRs) are not only expressed in Immune Cells (ICs) but also in ECs and that excessive endothelial activation through TLR interactions with endogenous ligands such as fibrinogen, Heparan Sulfate Proteoglycans (HSPGs), Fibronectin (FN), Tenascin-C (TN-C), hyaluronan and galectin-3, contributes to EC dysfunction promoting endothelial proliferation, migration, apoptosis and tube-like structures formation. Nevertheless, studies involving the endothelial TLR4 activation by specific ligands and their contribution to the small blood vessels formation in angiolipoma has not been considered. Herein, we show that in angiolipoma TLR4 and some of their ligands such as fibrinogen, FN, HSPGs including agrin, perlecan and Synd-1 and galectin-3 as well as some glycoconjugates associated to these ligands including VE-cadherin, VCAM-1, ICAM-1, PECAM-1, endoglin and CD44 were immunolocalized in the ECs from the small vessels and some ICs. We propose that in angiolipoma tissues galectin-3 oligomerization upon binding to these TLR4 endogenous ligands and glycoproteins associated can lead to the formation of gal-glycan lattices on the endothelial surface that might be facilitating not only the activation of TLR4, but also contributing to the vasculature formation regulated by signaling pathways mediated by certain cytokines, chemokines and growth factors.
No takes yet. Share an insight, caveat, or question.
Enrique Arciniegas (2024) conducted an observational in Angiolipoma (n=7). Endothelial TLR4 and endogenous ligands was evaluated on Presence and localization of endothelial TLR4 and endogenous ligands in angiolipoma tissues. TLR4 and its endogenous ligands, including galectin-3 and fibrinogen, were immunolocalized in the endothelial cells of small blood vessels in angiolipoma tissues, suggesting they contribute to vasculature formation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: